Divi's Laboratories Limited vs Shree Ganesh Biotech India Ltd

A side-by-side comparison of Divi's Laboratories Limited (DIVISLAB) and Shree Ganesh Biotech India Ltd (SHREEGANESHBIOTECHINDIALTD) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Divi's Laboratories Limited leads DIVISLAB vs SHREEGANESHBIOTECHINDIALTD on 11 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability40
  • Growth20
  • Size & financial health30
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

94.52
P/E ratio
0.00
14.90
P/B ratio
0.31
0.32%
Dividend yield
0.00%
₹96.75
EPS
₹0.01

Profitability

DIVISLAB takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

15.32%
Return on equity
0.96%
20.35%
Return on capital
0.76%
32.59%
EBITDA margin
-4.18%
24.32%
Net margin
1.22%

Growth

DIVISLAB takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.78%
Revenue CAGR (3Y)
-53.20%
12.09%
Profit CAGR (3Y)
-41.90%

Size & financial health

DIVISLAB takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹2.45L Cr
Market cap
₹20 Cr
₹10,560 Cr
Revenue
₹23 Cr
₹2,568 Cr
Net profit
₹0 Cr
0.00
Debt / equity even
0.00
Divi's Laboratories Limited
  • + ["Company has been maintaining a healthy dividend payout of 31.0%", "Company is almost debt free."]
  • − ["Stock is trading at 14.60 times its book value", "The company has delivered a poor sales growth of 8.7% over past five years."]
Shree Ganesh Biotech India Ltd
  • + ["Company is almost debt free.", "Stock is trading at 0.31 times its book value"]
  • − ["Though the company is reporting repeated profits, it is not paying out dividend", "Company has low interest coverage ratio.", "The company has delivered a poor sales growth of -22.0% over past five years.", "Company has a low return on equity of 0.84% over last 3 years.", "Working capital days have increased from 260 days to 861 days"]
Divi's Laboratories Limited full analysis Shree Ganesh Biotech India Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

DIVISLAB vs SHREEGANESHBIOTECHINDIALTD: Share Price, Valuation & Which to Buy | DocStoX